Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Geographic atrophy (GA) progressed more often in patients with better baseline vision and those with lesions closer to ...

Geographic atrophy is an advanced form of dry age-related macular degeneration that causes vision loss in older adults. Until recently, there were no treatments available to target the root cause.

Geographic atrophy is a subtype of advanced age-related macular degeneration (AMD). It causes blind spots in the center of vision and a permanent loss of visual sharpness. AMD progresses through ...

Apellis Pharma has become the first company to claim FDA approval for a drug to treat geographic atrophy (GA), a sight-robbing condition that accompanies age-related macular degeneration (AMD ...

to include longer-term administration for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (AMD). Izervay contains avacincaptad pegol, a PEGylated ...

The US Food and Drug Administration (FDA) has issued a complete response letter (CRL) for the supplemental new drug application (sNDA) of Astellas Pharma’s IZERVAY (avacincaptad pegol ...

The phase 1b trial will enrol patients with geographic atrophy secondary to age-related macular degeneration (AMD), a leading cause of blindness. While there are multiple therapies available for ...

Marci English, vice president, head of biopharma and ophthalmology development, Astellas, said: “Today’s submission comes as good news to people in Japan living with geographic atrophy who have no ...

Masked Analysis Shows Participants Receiving Oral Zervimesine for at Least 6 Months Experienced Slower Lesion Growth than Participants Receiving ...

(RTTNews) - Annexon, Inc.(ANNX), on Thursday announced presentations highlighting the potential of its investigational drug ANX007 for the treatment of geographic atrophy or GA, a form of advanced ...

The companies have successfully executed all milestones to date. About Geographic Atrophy (GA) GA is a chronic, progressive and irreversible retinal disease that occurs in people with late-stage ...